ID   RN123_HUMAN             Reviewed;        1314 AA.
AC   Q5XPI4; A1L4Q3; A6NLS5; Q5I022; Q6PFW4; Q71RH0; Q8IW18; Q9H0M8;
AC   Q9H5L8; Q9H9T2;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   10-MAY-2017, entry version 132.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF123;
DE            EC=2.3.2.27;
DE   AltName: Full=Kip1 ubiquitination-promoting complex protein 1;
DE   AltName: Full=RING finger protein 123;
DE   AltName: Full=RING-type E3 ubiquitin transferase RNF123 {ECO:0000305};
GN   Name=RNF123; Synonyms=KPC1; ORFNames=FP1477;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15531880; DOI=10.1038/ncb1194;
RA   Kamura T., Hara T., Matsumoto M., Ishida N., Okumura F.,
RA   Hatakeyama S., Yoshida M., Nakayama K., Nakayama K.;
RT   "Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1)
RT   at G1 phase.";
RL   Nat. Cell Biol. 6:1229-1235(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   HIS-854.
RC   TISSUE=Brain, Eye, Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 545-1314 (ISOFORM 1).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 535-1314 (ISOFORMS 1 AND 2),
RP   AND VARIANT HIS-854.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 892-1314 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [7]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=16227581; DOI=10.1128/MCB.25.21.9292-9303.2005;
RA   Hara T., Kamura T., Kotoshiba S., Takahashi H., Fujiwara K.,
RA   Onoyama I., Shirakawa M., Mizushima N., Nakayama K.;
RT   "Role of the UBL-UBA protein KPC2 in degradation of p27 at G1 phase of
RT   the cell cycle.";
RL   Mol. Cell. Biol. 25:9292-9303(2005).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Catalytic subunit of the KPC complex that acts as E3
CC       ubiquitin-protein ligase. Required for poly-ubiquitination and
CC       proteasome-mediated degradation of CDKN1B during G1 phase of the
CC       cell cycle. {ECO:0000269|PubMed:15531880,
CC       ECO:0000269|PubMed:16227581}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Component of the KPC complex composed of RNF123/KPC1 and
CC       UBAC1/KPC2. Interacts with UBAC1 and CDKN1B via its N-terminal
CC       domain. {ECO:0000269|PubMed:15531880,
CC       ECO:0000269|PubMed:16227581}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15531880}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q5XPI4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5XPI4-2; Sequence=VSP_020650;
CC   -!- PTM: Ubiquitinated, leading to its degradation. Deubiquitinated by
CC       USP19, thereby stimulating CDKN1B ubiquitin-dependent degradation.
CC       {ECO:0000250|UniProtKB:D3ZXK7}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14139.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB15607.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY744152; AAU93470.1; -; mRNA.
DR   EMBL; AC099668; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC041145; AAH41145.1; -; mRNA.
DR   EMBL; BC057392; AAH57392.2; -; mRNA.
DR   EMBL; BC088801; AAH88801.1; -; mRNA.
DR   EMBL; BC130632; AAI30633.1; -; mRNA.
DR   EMBL; AF370367; AAQ15203.1; -; mRNA.
DR   EMBL; AK022627; BAB14139.1; ALT_INIT; mRNA.
DR   EMBL; AK026968; BAB15607.1; ALT_INIT; mRNA.
DR   EMBL; AL136729; CAB66663.2; -; mRNA.
DR   CCDS; CCDS33758.1; -. [Q5XPI4-1]
DR   RefSeq; NP_071347.2; NM_022064.4. [Q5XPI4-1]
DR   RefSeq; XP_006713348.1; XM_006713285.1. [Q5XPI4-1]
DR   RefSeq; XP_011532297.1; XM_011533995.1. [Q5XPI4-1]
DR   RefSeq; XP_016862507.1; XM_017007018.1. [Q5XPI4-1]
DR   UniGene; Hs.553723; -.
DR   PDB; 2MA6; NMR; -; A=1247-1304.
DR   PDBsum; 2MA6; -.
DR   ProteinModelPortal; Q5XPI4; -.
DR   SMR; Q5XPI4; -.
DR   BioGrid; 121971; 40.
DR   IntAct; Q5XPI4; 13.
DR   MINT; MINT-1187266; -.
DR   STRING; 9606.ENSP00000328287; -.
DR   iPTMnet; Q5XPI4; -.
DR   PhosphoSitePlus; Q5XPI4; -.
DR   BioMuta; RNF123; -.
DR   DMDM; 74748090; -.
DR   EPD; Q5XPI4; -.
DR   MaxQB; Q5XPI4; -.
DR   PaxDb; Q5XPI4; -.
DR   PeptideAtlas; Q5XPI4; -.
DR   PRIDE; Q5XPI4; -.
DR   DNASU; 63891; -.
DR   Ensembl; ENST00000327697; ENSP00000328287; ENSG00000164068. [Q5XPI4-1]
DR   GeneID; 63891; -.
DR   KEGG; hsa:63891; -.
DR   UCSC; uc003cxh.5; human. [Q5XPI4-1]
DR   CTD; 63891; -.
DR   DisGeNET; 63891; -.
DR   GeneCards; RNF123; -.
DR   HGNC; HGNC:21148; RNF123.
DR   HPA; HPA065983; -.
DR   HPA; HPA071879; -.
DR   MIM; 614472; gene.
DR   neXtProt; NX_Q5XPI4; -.
DR   OpenTargets; ENSG00000164068; -.
DR   PharmGKB; PA134916827; -.
DR   eggNOG; KOG2242; Eukaryota.
DR   eggNOG; KOG4692; Eukaryota.
DR   eggNOG; ENOG410XQ4V; LUCA.
DR   GeneTree; ENSGT00530000063442; -.
DR   HOVERGEN; HBG079909; -.
DR   InParanoid; Q5XPI4; -.
DR   KO; K12169; -.
DR   OMA; AVMMYNL; -.
DR   OrthoDB; EOG091G015R; -.
DR   PhylomeDB; Q5XPI4; -.
DR   TreeFam; TF313546; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   GeneWiki; RNF123; -.
DR   GenomeRNAi; 63891; -.
DR   PRO; PR:Q5XPI4; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000164068; -.
DR   CleanEx; HS_RNF123; -.
DR   ExpressionAtlas; Q5XPI4; baseline and differential.
DR   Genevisible; Q5XPI4; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:LIFEdb.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 1.25.10.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR013320; ConA-like_dom.
DR   InterPro; IPR003877; SPRY_dom.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF00622; SPRY; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00449; SPRY; 1.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS50188; B302_SPRY; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Metal-binding; Methylation; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2   1314       E3 ubiquitin-protein ligase RNF123.
FT                                /FTId=PRO_0000250447.
FT   DOMAIN       74    254       B30.2/SPRY. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   ZN_FING    1254   1292       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   COMPBIAS   1237   1244       Poly-Ala.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     675    675       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:D3ZXK7}.
FT   MOD_RES     683    683       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q5XPI3}.
FT   VAR_SEQ    1295   1314       IVSVEDWEKGANTSTTSSAA -> TSNLLACLYPHWWEPSH
FT                                GPNCA (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020650.
FT   VARIANT      51     51       P -> R (in dbSNP:rs2960546).
FT                                /FTId=VAR_027561.
FT   VARIANT     387    387       R -> Q (in dbSNP:rs35620248).
FT                                /FTId=VAR_052106.
FT   VARIANT     596    596       K -> E (in dbSNP:rs35726701).
FT                                /FTId=VAR_052107.
FT   VARIANT     854    854       R -> H (in dbSNP:rs34823813).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_052108.
FT   CONFLICT    809    809       K -> R (in Ref. 5; BAB14139).
FT                                {ECO:0000305}.
FT   STRAND     1250   1253       {ECO:0000244|PDB:2MA6}.
FT   TURN       1255   1257       {ECO:0000244|PDB:2MA6}.
FT   STRAND     1258   1261       {ECO:0000244|PDB:2MA6}.
FT   STRAND     1264   1267       {ECO:0000244|PDB:2MA6}.
FT   TURN       1268   1270       {ECO:0000244|PDB:2MA6}.
FT   STRAND     1271   1273       {ECO:0000244|PDB:2MA6}.
FT   HELIX      1275   1281       {ECO:0000244|PDB:2MA6}.
FT   TURN       1282   1284       {ECO:0000244|PDB:2MA6}.
FT   STRAND     1296   1300       {ECO:0000244|PDB:2MA6}.
SQ   SEQUENCE   1314 AA;  148515 MW;  A0F8F4D68EAFB8E1 CRC64;
     MASKGAGMSF SRKSYRLTSD AEKSRVTGIV QEKLLNDYLN RIFSSSEHAP PAATSRKPLN
     FQNLPEHLDQ LLQVDNEEEE SQGQVEGRLG PSTVVLDHTG GFEGLLLVDD DLLGVIGHSN
     FGTIRSTTCV YKGKWLYEVL ISSQGLMQIG WCTISCRFNQ EEGVGDTHNS YAYDGNRVRK
     WNVTTTNYGK AWAAGDIVSC LIDLDDGTLS FCLNGVSLGT AFENLSRGLG MAYFPAISLS
     FKESVAFNFG SRPLRYPVAG YRPLQDPPSA DLVRAQRLLG CFRAVLSVEL DPVEGRLLDK
     ESSKWRLRGQ PTVLLTLAHI FHHFAPLLRK VYLVEAVLMS FLLGIVEKGT PTQAQSVVHQ
     VLDLLWLFME DYEVQDCLKQ LMMSLLRLYR FSPIVPDLGL QIHYLRLTIA ILRHEKSRKF
     LLSNVLFDVL RSVVFFYIKS PLRVEEAGLQ ELIPTTWWPH CSSREGKEST EMKEETAEER
     LRRRAYERGC QRLRKRIEVV EELQVQILKL LLDNKDDNGG EASRYIFLTK FRKFLQENAS
     GRGNMPMLCP PEYMVCFLHR LISALRYYWD EYKASNPHAS FSEEAYIPPQ VFYNGKVDYF
     DLQRLGGLLS HLRKTLKDDL ASKANIVIDP LELQSTAMDD LDEDEEPAPA MAQRPMQALA
     VGGPLPLPRP GWLSSPTLGR ANRFLSTAAV SLMTPRRPLS TSEKVKVRTL SVEQRTREDI
     EGSHWNEGLL LGRPPEEPEQ PLTENSLLEV LDGAVMMYNL SVHQQLGKMV GVSDDVNEYA
     MALRDTEDKL RRCPKRRKDI LAELTKSQKV FSEKLDHLSR RLAWVHATVY SQEKMLDIYW
     LLRVCLRTIE HGDRTGSLFA FMPEFYLSVA INSYSALKNY FGPVHSMEEL PGYEETLTRL
     AAILAKHFAD ARIVGTDIRD SLMQALASYV CYPHSLRAVE RIPEEQRIAM VRNLLAPYEQ
     RPWAQTNWIL VRLWRGCGFG YRYTRLPHLL KTKLEDANLP SLQKPCPSTL LQQHMADLLQ
     QGPDVAPSFL NSVLNQLNWA FSEFIGMIQE IQQAAERLER NFVDSRQLKV CATCFDLSVS
     LLRVLEMTIT LVPEIFLDWT RPTSEMLLRR LAQLLNQVLN RVTAERNLFD RVVTLRLPGL
     ESVDHYPILV AVTGILVQLL VRGPASEREQ ATSVLLADPC FQLRSICYLL GQPEPPAPGT
     ALPAPDRKRF SLQSYADYIS ADELAQVEQM LAHLTSASAQ AAAASLPTSE EDLCPICYAH
     PISAVFQPCG HKSCKACINQ HLMNNKDCFF CKTTIVSVED WEKGANTSTT SSAA
//
